Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

View source ↗

Summary

The PQRST study aims to predict the quality of response to treatments in patients with chronic graft-versus-host disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Chronic Graft Versus Host Disease | Status: RECRUITING